Prognostic value of miR-29a expression in pediatric acute myeloid leukemia
- 31 January 2013
- journal article
- Published by Elsevier BV in Clinical Biochemistry
- Vol. 46 (1-2), 49-53
- https://doi.org/10.1016/j.clinbiochem.2012.09.002
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- MicroRNA-29a Inhibited Epididymal Epithelial Cell Proliferation by Targeting Nuclear Autoantigenic Sperm Protein (NASP)*Online Journal of Public Health Informatics, 2012
- MicroRNA as a novel drug target for cancer therapyExpert Opinion on Biological Therapy, 2012
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011
- Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaPediatric Blood & Cancer, 2011
- MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?Leukemia Research, 2011
- Upregulated MicroRNA-29a by Hepatitis B Virus X Protein Enhances Hepatoma Cell Migration by Targeting PTEN in Cell Culture ModelPLOS ONE, 2011
- Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisHepatology, 2010
- microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemiaThe Journal of Experimental Medicine, 2010
- MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BProceedings of the National Academy of Sciences of the United States of America, 2007
- MicroRNA expression profiles classify human cancersNature, 2005